• Politics
  • Diversity, equity and inclusion
  • Financial Decision Making
  • Telehealth
  • Patient Experience
  • Leadership
  • Point of Care Tools
  • Product Solutions
  • Management
  • Technology
  • Healthcare Transformation
  • Data + Technology
  • Safer Hospitals
  • Business
  • Providers in Practice
  • Mergers and Acquisitions
  • AI & Data Analytics
  • Cybersecurity
  • Interoperability & EHRs
  • Medical Devices
  • Pop Health Tech
  • Precision Medicine
  • Virtual Care
  • Health equity

MED MOVES: Baptist Health South Florida has a new leader, and more

Article

NewYork-Presbyterian names a new COO, Northwell Health hires a VP of public health advocacy, and Temple University announces the medical school dean.

Bo Boulenger has been named the president and chief executive officer of Baptist Health South Florida.

Bo Boulenger

Bo Boulenger

Boulenger took the post effective Oct. 1. He succeeds longtime CEO Brian E. Keeley, who is retiring. Keeley served the healthcare organization for 50 years and has been CEO since 1986.

Keeley said in a statement that “the organization is in great hands with Bo guiding it into the future.”

“He is an outstanding leader, and in our long history he has been an integral partner who shares a mission-driven passion for excellent patient care delivered by the most skilled and compassionate team,” Keeley said.

Boulenger began his career with Baptist Health in 1985, when he joined South Miami Hospital. He later served as CEO at Homestead Hospital, and later as CEO of Baptist Hospital.

Most recently, Boulenger was president and chief operating officer for Baptist Health, where he was responsible for all of Baptist Health’s hospitals, outpatient facilities and physician practices. He also led all operations during natural disasters and crises, including, the COVID-19 pandemic response.

“I am humbled to be stepping into this role and honoring Brian’s legacy in leading Baptist Health into its next chapter with a well-established commitment to providing the highest quality care for our community,” Boulenger said in a statement. “I want to thank Brian for his visionary leadership and applaud his extraordinary achievements in expanding this organization from a single hospital to one of the largest and most trusted healthcare systems in the country.”

Baptist Health South Florida operates 12 hospitals and 200 care sites.

Brian Donley

Brian Donley

NewYork-Presbyterian announces new COO

Brian Donley has been named the executive vice president and chief operating officer of NewYork-Presbyterian.

He will take the new position on January 9, 2023. He comes to NewYork-Presbyterian from Cleveland Clinic, where he most recently served as chief executive officer of Cleveland Clinic London.

Donley will succeed Dr. Laura L. Forese, who plans to retire next year after nearly four decades with NewYork-Presbyterian. Donley will direct NewYork-Presbyterian’s strategies and operations.

Steven J. Corwin, president and CEO of NewYork-Presbyterian, said Donley is “an experienced leader, educator and innovator, whose vision and commitment to excellence, quality and compassion will be a tremendous asset to our health care system, our patients and the communities we serve.”

Donley said he’s excited about his new role.

“Throughout my career, I have been committed to transforming health care by prioritizing an ethos of empathy for our patients, their families, and one another, and focusing on our shared humanity,” Donley said in a statement. “I am honored to be working with the outstanding team at NewYork-Presbyterian and our two renowned medical schools, Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons.”

Donley joined Cleveland Clinic as an orthopedic surgeon in 1996. He has held several leadership positions within the health system, including chief of the clinical enterprise. He also served as president of the Cleveland Clinic regional hospitals and family health centers.

Sandra Lindsay

Sandra Lindsay

Northwell Health names VP of public health advocacy

Sandra Lindsay made history as the first American to receive the COVID-19 vaccine.

Lindsay, who is a recipient of the Presidential Medal of Freedom, has been named Northwell Health’s vice president of public health advocacy.

Lindsay spent 29 years in nursing, most recently serving as director of nursing critical care at Long Island Jewish (LIJ) Medical Center in New Hyde Park.

When the COVID-19 pandemic began and New York City became ground zero for the virus, Lindsay oversaw expansion of the hospital’s intensive care unit to care for critically ill patients.

In December 2020, she volunteered to become the first recipient of the Pfizer COVID-19 vaccine, and gained international recognition. Her ID badge and scrubs are in the Smithsonian’s National Museum of American History.

Lindsay is looking forward to her new role.

“I plan to work collaboratively with my colleagues to positively influence social and health issues that are priorities for our communities in New York, throughout the U.S. and globally,” Lindsay said in a statement. “I chose a career in health care because I believe in raising the health of everyone. I plan to advance the mission at Northwell Health of compassionate and equitable care.”

A native of Jamaica, Lindsay emigrated to the United States from Jamaica in 1986. Seven years later, she was the valedictorian of her nursing program at Borough of Manhattan Community College in 1993. She joined Lenox Hill Hospital one year later as an oncology nurse.

Michael Dowling, president and CEO of Northwell Health, described Lindsay as “an amazing profile in leadership and compassion, someone who exemplifies the best of the American experience and the values of this health system.”

Amy Goldberg

Amy Goldberg

Temple University announces dean of medical school

After serving in an interim capacity for 18 months, Amy J. Goldberg has been named the dean of Temple University’s Lewis Katz School of Medicine.

Goldberg is now the George S. and Louise C. Peters Chair of Surgery and Temple University Health System surgeon-in-chief.

Temple University President Dr. Jason Wingard said in a statement, “Her commitment to leading Katz to best-in-class status was absolute from moment one.”

“Dr. Goldberg has cross disciplinary expertise and comprehensive command of operational functions at the school – and the savvy to lead it to new heights of innovation and difference-making,” Wingard said.

Goldberg joined Temple’s faculty in 1991 and has held a host of leadership positions at the university.

As dean of the medical school, Goldberg is focused on improving the health and wellness of students. Goldberg said she wants to transform the student experience at Temple’s medical school, according to a university news release.

“If we don’t take good care of students, how can we expect them to take good care of patients?” Goldberg said in a news release. “At Katz, we want students to flourish and thrive.”

Michael Young, the CEO of Temple University Health System, praised Goldberg’s “forward-thinking observations – and astute ability to see the global picture as well as the details.”

A trauma surgeon, Goldberg spent 13 years leading Temple’s trauma service.

Mark Taubman

Mark Taubman

University of Rochester Medical Center discloses retirement plan

Mark B. Taubman, CEO of the University of Rochester Medical Center and dean of the School of Medicine and Dentistry, has announced his intention to step down late next year.

Taubman, who is 72, plans to step down as CEO and dean on Dec. 31, 2023. He will stay later if the university hasn’t found a successor.

University of Rochester President Sarah Mangelsdorf made the announcement during a meeting of the board of trustees last week.

“I have been honored to lead this great institution and am proud of the significant advances we have achieved, particularly over the past two years,” Taubman said in a statement. “With so many of the goals of our strategic plan either accomplished or well underway, the time feels right to begin succession planning to assure our Medical Center is structured for a strong and vibrant future.”

Taubman said that he aims to continue working on addressing the shortage of healthcare workers, improving the medical center’s financial performance and expand the organization’s research mission.

Gail W. Kosyla

Gail W. Kosyla

Yale New Haven Health hires CFO

Gail W. Kosyla has been named the chief financial officer of Yale New Haven Health.

She will take the post November 28.

Kosyla has been working with RWJBarnabas Health since 2019, most recently serving as executive vice president of system financial operations.

“This is a unique and challenging time in healthcare with many exciting opportunities for the future,” Kosyla said in a statement. “I am honored to join the team at Yale New Haven Health and I am thrilled for the opportunity to serve as CFO at this highly regarded health system.”

Christopher O’Connor, CEO and president of Yale New Haven Health, said he’s “delighted” to have Kosyla join the system.

“Her extensive experience in healthcare, and in an academic health system specifically, will help us shape the future of our health system in the years ahead,” O’Connor said in a statement. “We are fortunate to have recruited someone with Gail’s incredible talents.”

Kosyla served as the chief financial officer and senior vice president of strategy at Hunterdon Healthcare System in New Jersey from 2012 to 2019.

She spent several years at Arthur Andersen. Kosyla began her healthcare career at Catholic Health Initiatives/Catholic Health East in Pennsylvania and later served as executive vice president and CFO at St. Francis Medical Center in Trenton, N.J. in 2001.

In 2008, Kosyla became a senior vice president and chief financial officer at St. Mary Medical Center in Langhorne, Pa.









Recent Videos
Image: Ron Southwick, Chief Healthcare Executive
Image: U.S. Dept. of Health & Human Services
Image: Johns Hopkins Medicine
Image credit: ©Shevchukandrey - stock.adobe.com
Image: Ron Southwick, Chief Healthcare Executive
Image credit: HIMSS
Related Content
© 2024 MJH Life Sciences

All rights reserved.